![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Yu D. S. Hsieh D. S. Chang S. Y.
Publisher: Informa Healthcare
ISSN: 1521-0375
Source: Archives of Andrology, Vol.52, Iss.5, 2006-09, pp. : 389-395
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of Chemotherapy in Hormone-Refractory Prostate Cancer
Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer
Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer
Urologia Internationalis, Vol. 65, Iss. 1, 2000-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer
Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. :